You have Guest access.
Log In
Sayed S. Daoud
I-XII
Front matter
3-35
I / Proteomics Technologies
Current and Emerging Mass Spectrometry Instrumentation and Methods for Proteomic Analyses
39-77
II / Cell Signaling Proteomics
39-57
Integration of Genomics and Proteomics in Dissecting p53 Signaling
59-77
Proteomic Profiling of Tyrosine Kinases as Pharmacological Endpoints for Targeted Cancer Therapy
81-207
III / Tumor Proteomics
81-99
Oncoproteomics for Personalized Management of Cancer
101-120
Application of Serum and Tissue Proteomics to Understand and Detect Solid Tumors
121-137
Insight on Renal Cell Carcinoma Proteome
139-159
Proteomics in Lung Cancer
161-187
Proteomic Strategies of Therapeutic Individualization and Target Discovery in Acute Myeloid Leukemia
189-207
New Tumor Biomarkers Practical Considerations Prior to Clinical Application
211-258
IV / Bioinformatics and Regulatory Aspects of Proteomics
211-235
Annotating the Human Proteome From Establishing a Parts List to a Tool for Target Identification
237-258
Regulatory Issues in the Co-Development of Oncology Drugs and Proteomic Tests: An Overview
259-264
Back matter
This page requires script.
Frequently asked questions General info on journals and books Send us your feedback Impressum Contact us
© Springer, Part of Springer Science+Business Media Privacy, Disclaimer, Terms & Conditions, and Copyright Info